ANDREW SINCLAIR, PHD.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

SOLENO THERAPEUTICS INC

Filing Date Source Excerpt
2021-04-21 "Dr. Sinclair... received a Ph.D. in chemistry and genetic engineering... and a B.Sc. in microbiology"
2024-04-22 "Dr. Sinclair has been a member of our Board of Directors since December 2018... Since 2008, Dr. Sinclair has held various positions at Abingworth LLP... Dr. Sinclair received a BSc in Microbiology from King’s College London and his Ph.D. in Chemistry and Genetic Engineering..."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-06-10